Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ocular Therapeutix (OCUL) Interest Coverage Ratio (2016 - 2026)

Ocular Therapeutix has reported Interest Coverage Ratio over the past 14 years, most recently at 33.61 for Q1 2026.

  • For Q1 2026, Interest Coverage Ratio fell 56.92% year-over-year to 33.61; the TTM value through Mar 2026 reached 25.75, down 57.87%, while the annual FY2025 figure was 22.82, 80.32% down from the prior year.
  • Interest Coverage Ratio for Q1 2026 was 33.61 at Ocular Therapeutix, down from 24.63 in the prior quarter.
  • Over five years, Interest Coverage Ratio peaked at 4.83 in Q4 2023 and troughed at 33.61 in Q1 2026.
  • A 5-year average of 15.02 and a median of 12.75 in 2023 define the central range for Interest Coverage Ratio.
  • Biggest five-year swings in Interest Coverage Ratio: surged 53.92% in 2023 and later crashed 237.12% in 2024.
  • Year by year, Interest Coverage Ratio stood at 10.48 in 2022, then surged by 53.92% to 4.83 in 2023, then plummeted by 237.12% to 16.28 in 2024, then plummeted by 51.28% to 24.63 in 2025, then crashed by 36.45% to 33.61 in 2026.
  • Business Quant data shows Interest Coverage Ratio for OCUL at 33.61 in Q1 2026, 24.63 in Q4 2025, and 22.88 in Q3 2025.